Search research articles
Contact Us
Filters
Showing results (81-90 of 139) with videos related to
Page
of 14
Sort By:
The Journal of Orthopaedic and Sports Physical Therapy
|
January 1, 1988
The Treatment of Soft Tissue Hemorrhages in a Severe Classical Hemophiliac with an Unusual Antibody to Factor VIII
O K Abereoje, M Heim, U Martinowitz, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
October 1, 1988
The hemostatic effect of transfusing fresh whole blood versus platelet concentrates after cardiac operations
R Mohr, U Martinowitz, J Lavee, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 24, 2016
The feasibility of using concentrates containing factor IX for continuous infusion
S Schulman, S Gitel, A Zivelin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 24, 2016
Multifocal pseudotumour in a single limb
M Heim, H Horoszowski, S Schulman, et al.
Thrombosis and Haemostasis
|
March 4, 1999
Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease
A Lubetsky, S Schulman, D Varon, et al.
Journal of Medical Virology
|
June 1, 1993
Response of hemophilic patients to poliovirus vaccination: correlation with HIV serology and with immunological parameters
D Varon, R Handsher, R Dardik, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 3, 2009
Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors
G Kenet, A Lubetsky, J Luboshitz, et al.
The Journal of Trauma
|
September 6, 2001
Recombinant activated factor VII for adjunctive hemorrhage control in trauma
U Martinowitz, G Kenet, E Segal, et al.
Acta Neurochirurgica
|
May 14, 2008
Administration off label of recombinant factor-VIIa (rFVIIa) to patients with blunt or penetrating brain injury without coagulopathy
M Zaaroor, J F Soustiel, B Brenner, et al.
European Journal of Clinical Pharmacology
|
January 1, 1985
Mechanism of warfarin potentiation by amiodarone: dose--and concentration--dependent inhibition of warfarin elimination
S Almog, N Shafran, H Halkin, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 139) with videos related to
Sort By:
Page
of 14
The Journal of Orthopaedic and Sports Physical Therapy
|
January 1, 1988
The Treatment of Soft Tissue Hemorrhages in a Severe Classical Hemophiliac with an Unusual Antibody to Factor VIII
O K Abereoje, M Heim, U Martinowitz, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
October 1, 1988
The hemostatic effect of transfusing fresh whole blood versus platelet concentrates after cardiac operations
R Mohr, U Martinowitz, J Lavee, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 24, 2016
The feasibility of using concentrates containing factor IX for continuous infusion
S Schulman, S Gitel, A Zivelin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 24, 2016
Multifocal pseudotumour in a single limb
M Heim, H Horoszowski, S Schulman, et al.
Thrombosis and Haemostasis
|
March 4, 1999
Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease
A Lubetsky, S Schulman, D Varon, et al.
Journal of Medical Virology
|
June 1, 1993
Response of hemophilic patients to poliovirus vaccination: correlation with HIV serology and with immunological parameters
D Varon, R Handsher, R Dardik, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 3, 2009
Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors
G Kenet, A Lubetsky, J Luboshitz, et al.
The Journal of Trauma
|
September 6, 2001
Recombinant activated factor VII for adjunctive hemorrhage control in trauma
U Martinowitz, G Kenet, E Segal, et al.
Acta Neurochirurgica
|
May 14, 2008
Administration off label of recombinant factor-VIIa (rFVIIa) to patients with blunt or penetrating brain injury without coagulopathy
M Zaaroor, J F Soustiel, B Brenner, et al.
European Journal of Clinical Pharmacology
|
January 1, 1985
Mechanism of warfarin potentiation by amiodarone: dose--and concentration--dependent inhibition of warfarin elimination
S Almog, N Shafran, H Halkin, et al.
Page
of 14